| Christopher C Carpenter, OD | |
|
916 W Chandler Blvd, Suite 1, Chandler, AZ 85225-2514 | |
| (480) 963-7172 | |
| (480) 782-1689 |
| Full Name | Christopher C Carpenter |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 24 Years |
| Location | 916 W Chandler Blvd, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538132311 | NPI | - | NPPES |
| 539570 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1104 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chandler Eyecare Llc | 9234021593 | 4 |
| Seville Eye Center Llc | 7214030527 | 4 |
News Archive
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
Researchers with the Resuscitation Outcomes Consortium, which includes the University of Alabama at Birmingham, report Sept. 1 in the New England Journal of Medicine on the first two large-scale ROC trials. Both trials were evaluating new strategies for cardiopulmonary resuscitation following cardiac arrest.
AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.
In science, sometimes a new perspective can turn our interpretation of the data upside-down, and necessitate a paradigm shift.
› Verified 6 days ago
| Provider Name | Chandler Eyecare Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1871714667 PECOS PAC ID: 9234021593 Enrollment ID: O20040330000223 |
News Archive
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
Researchers with the Resuscitation Outcomes Consortium, which includes the University of Alabama at Birmingham, report Sept. 1 in the New England Journal of Medicine on the first two large-scale ROC trials. Both trials were evaluating new strategies for cardiopulmonary resuscitation following cardiac arrest.
AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.
In science, sometimes a new perspective can turn our interpretation of the data upside-down, and necessitate a paradigm shift.
› Verified 6 days ago
| Provider Name | Seville Eye Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750455234 PECOS PAC ID: 7214030527 Enrollment ID: O20070307000090 |
News Archive
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
Researchers with the Resuscitation Outcomes Consortium, which includes the University of Alabama at Birmingham, report Sept. 1 in the New England Journal of Medicine on the first two large-scale ROC trials. Both trials were evaluating new strategies for cardiopulmonary resuscitation following cardiac arrest.
AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.
In science, sometimes a new perspective can turn our interpretation of the data upside-down, and necessitate a paradigm shift.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher C Carpenter, OD 21309 E Excelsior Ave, Queen Creek, AZ 85242-5566 Ph: (480) 540-4056 | Christopher C Carpenter, OD 916 W Chandler Blvd, Suite 1, Chandler, AZ 85225-2514 Ph: (480) 963-7172 |
News Archive
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
Researchers with the Resuscitation Outcomes Consortium, which includes the University of Alabama at Birmingham, report Sept. 1 in the New England Journal of Medicine on the first two large-scale ROC trials. Both trials were evaluating new strategies for cardiopulmonary resuscitation following cardiac arrest.
AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.
In science, sometimes a new perspective can turn our interpretation of the data upside-down, and necessitate a paradigm shift.
› Verified 6 days ago
Dr. David Christensen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2050 N Alma School Rd, Chandler, AZ 85224 Phone: 480-786-1075 Fax: 480-786-0476 | |
James Sterenberg, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1717 W Chandler Blvd, Chandler, AZ 85224 Phone: 480-821-7565 | |
Dr. Nancy Nan-yin Liaw, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1815 E Queen Creek Rd, Ste. #2, Chandler, AZ 85286 Phone: 480-895-2020 Fax: 480-699-6724 | |
Vision Edge Eye Center Optometrist Medicare: Medicare Enrolled Practice Location: 7130 W Chandler Blvd Ste 19, Chandler, AZ 85226 Phone: 480-961-8999 Fax: 480-961-5009 | |
Kristin Renee Cerni, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 220 N Mckemy Ave, Chandler, AZ 85226 Phone: 480-518-1697 | |
Dr. Neal Weinstein, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 220 N Mckemy Ave, Chandler, AZ 85226 Phone: 480-961-1865 Fax: 480-961-4605 | |
Dr. David Palmieri, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 220 N Mckemy Ave, Chandler, AZ 85226 Phone: 480-961-1865 Fax: 480-961-1865 |